FibroBiologics Secures European Patent for Fibroblast Delivery of Cancer Treatments

PUBT · 1d ago
FibroBiologics Secures European Patent for Fibroblast Delivery of Cancer Treatments
  • FibroBiologics received a European patent covering fibroblasts engineered to deliver oncolytic viruses to tumors.
  • Patent protection extends to the modified cells for cancer treatment alongside existing therapies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611050830PR_NEWS_USPR_____DA89312) on November 05, 2026, and is solely responsible for the information contained therein.